MILAN, Italy, April 20 /PRNewswire/ -- The European Health Technology Institute for Socio-Economic Research (EHTI) today presents at a high level workshop at Bocconi University in Milan, Italy. The workshop brings together leading European and Italian experts to exchange views on the role and implementation of health technology assessment (HTA) in Italy and across Europe and takes place just a few days before the European Parliament's plenary session vote on 23 April on the Directive on the Application of Patients' Rights in Cross-Border Healthcare. In Article 17 of the Directive, the European Commission aims to establish a framework for European cooperation in HTA.

When want to understand something complex, we make something similar but simpler - a model.  Models in engineering re-imagine complex structures as sticks, strings, and hinges.  Biology uses simpler living systems, like yeast and mice.  But plenty of scientific questions defy our tried-and-true modeling strategies.  If a system is too complex or too slow for us to accurately simplify, we must wait for a model to present itself.  

STEVENAGE, England, April 20 /PRNewswire/ -- As the weather hots up, Fitness Footwear is rapidly expanding their range of summer sandals to meet the new need for fit flops and other forms of exercise sandals.

The sun is out, spring is here and it won't be long until the sun kissed beach bodies are strolling across the beaches of Great Britain once again. But how do those bodies stay in such terrific shape in time for summer?

Fit Flops are just one of the answers. Styled to resemble a comfortable flip flop and now with a new range of winter slipper designs, they are the perfect footwear to stay slim and trim all year round, from going about the daily routine to relaxing at home.

PITTSBURGH, April 20 /PRNewswire/ --

Mylan Inc. (Nasdaq: MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.2% controlling interest, has been selected by the Clinton HIV/AIDS Initiative (CHAI) under its UNITAID-funded projects as the primary supplier of five antiretroviral (ARV) drugs used in second-line HIV/AIDS treatment regimens. Matrix also has been selected as the primary supplier of seven ARVs used for pediatric treatment.

SAN DIEGO, April 20 /PRNewswire/ --

- Trial Will Evaluate Safety, Proof of Mechanism of a Potential Oral Antagonist for the Treatment of Asthma and COPD

Amira Pharmaceuticals, Inc., announced today the initiation of a Phase I clinical study of AM211, its internally discovered oral drug candidate for the treatment and control of inflammatory and allergic diseases linked to the arachidonic acid pathway.

AM211 is an oral, selective antagonist of the receptor DP2, which recent studies have shown to be a potential target for the treatment of asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The Phase I study is designed to obtain safety and proof of mechanism data for AM211.

NORTHAMPTON, England, April 20 /PRNewswire/ -- Northampton-based VSG, one of the most successful companies in the UK security sector, has achieved the accolade of inclusion in the annual Sunday Times PricewaterhouseCoopers Profit Track 100 league table. Published on Sunday 19th April, this prestigious table lists the 100 private companies with the fastest growth in profits over the last three years of available audited accounts.

VSG's profits grew from GBP999,000 in 2005 to GBP4.2 million in 2008 - an annual rate of 61% - putting the company at 61st position in the league table. The company was the largest employer in the Midlands to be listed, having created 1,980 jobs over the last three years.

DUBLIN, April 20 /PRNewswire/ -- EcoSecurities, a leading company in the business of sourcing, developing and trading emission reductions from greenhouse gas abatement projects, Conservation International, The Climate, Community Biodiversity Alliance and ClimateBiz, announce the findings of their 'Forest Carbon Offsetting Survey 2009', one of the first research studies to focus on corporate attitudes concerning carbon offsets from forestry projects.

Highlights of the research, which sampled 120 global, multinational and regional organisations, and 21 carbon companies, included:

CHENNAI, India, April 20 /PRNewswire/ -- Sify Technologies Limited (Nasdaq: SIFY), a leader in Consumer Internet Services and Enterprise Services in India with global delivery capabilities, today announced that it will report its financial results for the fourth quarter and full fiscal year 2008-2009 ended March 31, 2009 on Friday, April 24, 2009 before the market opens.

In conjunction with the earnings release, Sify will host a conference call at 8:30am ET hosted by Mr. Raju Vegesna, Chairman of the Board and Chief Executive Officer, Mr. CVS Suri, Chief Operating Officer and Mr. MP Vijay Kumar, Chief Financial Officer.

DENVER, April 20 /PRNewswire/ --

- Key Data are New Releases for the Company Building on Milestones with Recent FDA Meetings and Technology Discoveries -

LONDON, April 20 /PRNewswire/ --

- Welcomes CRA International as a New Sponsor

ICIS (http://wwww.icis.com), the world's leading information provider for the global chemical and oil industry, today calls for entries for its sixth annual ICIS Innovation Awards (http://www.icis.com/awards), designed to recognise outstanding technological and business innovation in the chemical industry.

Dow Corning (http://www.dowcorning.com) is the overall lead sponsor for the Awards, as it has been from their inception in 2004. This year, ICIS is pleased to welcome consultancy CRA International ( http://www.crai.com/chemicals) as the sponsor of the Best Innovation category.